Benitec Biopharma (BNTC)

• Market cap: $411M
• 1 day: -0.32%
• 5 days: 4.54%
• 1 month: 14.23%
• 3 months: 33.3%
• 6 months: 13.82%
• Year to date: 29.55%
• 1 year: 39.48%
• 5 years: -68.36%
• 10 years: -99.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19